Latest news
Loading news…
Veracyte
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States Founded 2006 501-1000 employees For Profit
Veracyte develops molecular diagnostic tests to improve patient outcomes and lower healthcare costs.
Veracyte on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$1.05B
Funding Rounds
10
Last Funding
Acquisitions
4
Monthly Visits
Contacts
362
Ticker
VCYT
NASDAQ
Patents
43
53 trademarks
About Veracyte
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- VCYT
- Exchange
- NASDAQ
- IPO date
- Oct 30, 2013
- Raised at IPO
- $65M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 47
- Mobile apps
- 2
- Active products
- 24
- Patents granted
- 43
- Trademarks
- 53
- IT spend
- $39.9M
Company Info
- Founded
- 2006
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 309
- Events
- 2
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- Oct 30, 2013
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.1
- Trend (90d)
- 6.8
- Last leadership hire
- May 5, 2026
Veracyte Funding Rounds
10 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 10Show
Page 1 / 2
Veracyte Acquisitions
5 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| C2i Genomics | — | 2026-07-30 | Veracyte | GeneticsHealth CareHealth DiagnosticsTherapeutics | United States |
| C2i Genomics | $70M | 2024-01-08 | Veracyte | GeneticsHealth CareHealth DiagnosticsTherapeutics | United States |
| HalioDx | $317.84M | 2021-06-01 | Veracyte | Health DiagnosticsMedicalOncologyPharmaceutical | France |
| Decipher Biosciences | $600M | 2021-02-03 | Veracyte | BiotechnologyHealth CareMedicalPharmaceutical | United States |
| Allegro Diagnostics | $21M | 2014-09-04 | Veracyte | BiotechnologyEducationHealth DiagnosticsMedical | United States |
1–5 of 5Show
Page 1 / 1
Veracyte Key People
Co-founder and Director
Board of Directors
SVP, GM of Pulmonology and Market Access
Chief Human Resources Officer
CEO
Chief Development and Technology Officer
362
professional contacts at Veracyte
Contact execs at Veracyte →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Veracyte
Loading news…
FAQs about Veracyte
People who checked this page also checked these
Sectors Veracyte invests & acquires in
Browse the full Acquirezy directory.